SUSMED has announced that it, together with ASKA Pharmaceutical Co., Ltd., has started a specified clinical trial using a digital therapeutics app designed for patients with Premenstrual Syndrome or Premenstrual Dysphoric Disorder, in collaboration with Mariko Ogawa, Ph.D., a specially-appointed professor at Fukushima Medical Center for Children and Woman of Fukushima Medical University.
The details can be read here.